NCBiotech News

Fervent Pharmaceuticals, a clinical-stage drug development company based in Greenville, has announced positive results from its Phase 2A clinical trial of FP-101, a non-hormonal, non-herbal, non-antidepressant treatment of the vasomotor symptoms that accompany menopause.

Cary-based agricultural technology company Verdesian Life Sciences' global workforce of 225 strives to advance the company’s goal “to enable a sustainable future for farmers through nutrient use efficiency.”

Durham-based Aerie Pharmaceuticals, a developer of therapies for eye diseases, has received approval from the U.S. Food and Drug Administration to begin selling Rocklatan, a once-daily eye drop for reducing high intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

North Carolina’s Research Triangle region is among the nation’s largest and fastest-growing markets in the life sciences, according to a new report by Los Angeles-based CBRE Group, the world’s largest commercial real estate services and investment firm.

Paris-based biotechnology company Cellectis announced plans today to invest nearly $70 million and create 200 jobs in Raleigh, at what will become its first North American manufacturing facility.

Want to know what people think of Raleigh? Or Charlotte? Where to buy your next McMeal? Then check out Numbeo. It's saying Raleigh and Charlotte are among the best metros in the world for quality of life.

Durham-based Precision BioSciences, a genome-editing company focused on creating better foods and medicines, wants to raise up to $100 million in an initial public offering (IPO) of stock.

Dignify Therapeutics, a virtual drug development company in Research Triangle Park, has received a $3.6 million federal grant to help develop its lead drug candidate for a future Phase 1 clinical study.

A panel of venture investment fund managers offered their insights into raising venture capital in the life sciences Wednesday during the 2019 CED Life Science Conference at the Raleigh Convention Center.

For any bioscience entrepreneurs in North Carolina who may be tempted to exaggerate claims about their products and technologies, investigative journalist John Carreyrou has some advice: do so at your own peril.

Several North Carolina Biotechnology Center portfolio companies are among the array of life science startups presenting their wares at the 2019 CED Life Science Conference today and Wednesday at the Raleigh Convention Center, including some that presented a year ago.

It’s no secret that agriculture is highly dependent on climate, and the effects of global warming on crops are a complex problem. Those recognitions were jumping-off points for discussions from executives of two of North Carolina’s leading global agricultural biotechnology companies during NCBiotech's Ag Tech Professional Forum.

CiVentiChem has received its first U.S. Food and Drug Administration approval for a generic commercial active pharmaceutical ingredient (API) manufactured at its Cary headquarters.

With uncertain weather forecast, the NCBiotech RTP office is opening at noon on Wednesday February 20.

Many of us will be checking in from home. Please stay safe out there.

Glenmark Pharmaceuticals, the largest pharmaceutical manufacturer in the Greater Charlotte region, is bringing a big “Help Wanted” message to the North Carolina Biotechnology Center’s monthly Jobs Network event, in search of production employees to help meet its fast-growing demand.